COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
30,551 Articles (22,400 medRxiv, 8,151 bioRxiv)
Most recent first Previous | Page 3056: Articles 30551-30551
Chen, T., Rui, J., Wang, Q., Zhao, Z., Cui, J.-A., Yin, L.
10.1101/2020.01.19.911669 — Posted: 2020-01-19
Discussion: Onsite
The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.
Subject Areas
-
Biochemistry (2903)
-
Bioengineering (2005)
-
Bioinformatics (10611)
-
Biophysics (4359)
-
Cancer Biology (3357)
-
Cell Biology (4766)
-
Clinical Trials* (136)
-
Developmental Biology (2972)
-
Ecology (4684)
-
Epidemiology* (2042)
-
Evolutionary Biology (7435)
-
Genetics (5642)
-
Genomics (7039)
-
Immunology (2550)
-
Microbiology (7858)
-
Molecular Biology (3146)
-
Neuroscience (19387)
-
Paleontology (144)
-
Pathology (495)
-
Physiology (1212)
-
Plant Biology (2863)
-
Synthetic Biology (931)
-
Systems Biology (2933)
-
Zoology (480)
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).